Search

everythinglearnresearchcommunity

for

Search:↓

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Targeting the AhR pathway may help treat alopecia areata.

Immune cells and cytokines significantly affect pathological scar development.

Restoring hair follicle immune privilege may help treat alopecia areata.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Keeping human skin stem cells is easier with low temperatures and mTOR inhibition.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

iNKT cells help develop and maintain healthy skin in young mice.

Hair follicles regulate immune cells in the skin, and disrupting certain pathways can lead to skin issues and infections.

Blocking certain proteins on immune cells may help treat alopecia areata.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Vitamin D affects many body functions and its interaction with microRNAs could help treat related diseases.